4LV-22469-79360
1 vaccination
3 coded responses
4 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 786 / TX
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Registered in v-safe
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold symptoms: runny nose, sneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activitiesno matching call case
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Nasal pruritus, Nasopharyngitis, Rhinorrhoea — Feeling: Good · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Cold symptoms, but getting better. No more itchy, runny nose. Cough setting in.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Nasopharyngitis — Feeling: Good · Fatigue or tirednessFree text: Cough from a coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-12 | priority 2/3 |
1 report(s) with no call case — see the timeline.
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Cold symptoms: runny nose, sneezing
Systemic reaction (other): Cold symptoms, but getting better. No more itchy, runny nose. Cough setting in.
Systemic reaction (other): Cough from a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Nasal pruritus | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release